Ategra Capital Management’s RTX Corp RTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,702
Closed -$556K 79
2024
Q1
$556K Hold
5,702
0.25% 59
2023
Q4
$480K Sell
5,702
-233
-4% -$18.4K 0.21% 62
2023
Q3
$427K Sell
5,935
-6,631
-53% -$568K 0.23% 65
2023
Q2
$1.23M Buy
12,566
+10,791
+608% +$1.06M 0.66% 37
2023
Q1
$543K Sell
1,775
-7,800
-81% -$768K 0.3% 63
2022
Q4
$966K Buy
9,575
+3,122
+48% +$294K 0.49% 44
2022
Q3
$528K Buy
+6,453
New +$584K 0.27% 64
2022
Q1
Sell
-8,365
Closed -$720K 110
2021
Q4
$720K Sell
8,365
-128
-2% -$11.2K 0.31% 60
2021
Q3
$730K Sell
8,493
-13
-0.2% -$1.11K 0.35% 59
2021
Q2
$726K Buy
8,506
+128
+2% +$10.8K 0.35% 55
2021
Q1
$647K Buy
+8,378
New +$611K 0.36% 54
2020
Q4
Sell
-4,530
Closed -$261K 101
2020
Q3
$261K Buy
+4,530
New +$276K 0.23% 71
2020
Q2
Sell
-4,063
Closed -$241K 91
2020
Q1
$241K Buy
4,063
+143
+4% +$12.1K 0.28% 66
2019
Q4
$369K Buy
3,920
+14
+0.4% +$1.27K 0.31% 58
2019
Q3
$336K Hold
3,906
0.3% 69
2019
Q2
$320K Hold
3,906
0.3% 76
2019
Q1
$317K Buy
+3,906
New +$297K 0.31% 73

Other funds holding RTX

Ategra Capital Management's RTX Position: Q2 2024 in Review

Ategra Capital Management sold out of RTX Corp (RTX) in Q2 2024, closing a stake of 5,702 shares — an estimated $556K sold.

Ategra Capital Management first reported a position in RTX in Q1 2019 and held it in 17 quarters. The position peaked at $1.23M in Q2 2023. 2,536 funds tracked by Wall St. Rank hold RTX as of Q2 2024.

  • Ategra Capital Management reported no remaining RTX Corp position as of Q2 2024 after selling out during the quarter.
  • Ategra Capital Management sold 5,702 RTX Corp shares in Q2 2024, an estimated $556K.
  • Ategra Capital Management first reported a position in RTX Corp in Q1 2019 and held it in 17 quarters.
  • Ategra Capital Management's RTX Corp position peaked at $1.23M in Q2 2023.
  • 2,536 funds tracked by Wall St. Rank held RTX Corp as of Q2 2024.

Based on Ategra Capital Management's 13F filing for Q2 2024, filed 14 Feb 2025.